Skip to content

Clinical trials

Phase 1/2 Ovarian Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1/2 Country / region: United States Clear all

212 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20023
20034
20044
20055
20063
20075
20083
20097
20104
20112
20127
20133
20147
20158
201611
201714
20189
201913
202014
202116
202213
202313
202410
202512
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed79
Terminated54
Recruiting44
Active, not recruiting17
Unknown status8
Withdrawn7
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)7
AstraZeneca5
M.D. Anderson Cancer Center5
Memorial Sloan Kettering Cancer Center5
Genmab4
Incyte Biosciences International Sàrl4
Incyte Corporation4
Roswell Park Cancer Institute4
NextCure, Inc.3
Arvinas Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms212
Breast Neoplasms58
Endometrial Neoplasms51
Carcinoma, Non-Small-Cell Lung46
Fallopian Tube Neoplasms44
Colorectal Neoplasms40
Pancreatic Neoplasms37
Uterine Cervical Neoplasms32
Carcinoma, Ovarian Epithelial31
Melanoma30

Trials

Showing 1 to 25 of 212. Each trial links to its page on Pharma Observatory.

112 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.